The question
Does the spread of damaged proteins from cell to cell drive brain degeneration?
This is the specific idea being tested.
The Hypothesis Critic · A guide for everyone
Prion-like Spread of Misfolded Proteins
Does the spread of damaged proteins from cell to cell drive brain degeneration?
What you need to knowDamaged proteins can spread in experiments. That does not establish spread as the main driver of natural disease.Relative explanatory fit: Alternative ranked ahead
Why the alternative fits better: Cell identity and internal protein handling help explain injury beyond where protein material travels.
Review summary
Claim assessed: Misfolded tau and alpha-synuclein propagate cell to cell by templated conversion, driving progressive neurodegeneration.
Finding: The weakest-link conjunction returns Γ. Physiological host substrate can be recruited after imposed seeds, and source-restricted transfer and receptor perturbations demonstrate substantial capabilities. Selective blockade of spontaneous propagation has not established progression necessity in both disease families. Canonical PrP loss/rescue is stronger comparator evidence and is not transferred to the nominal tau/alpha-synuclein claim. Host state, compartment and intracellular toxicity constrain a universal spread-driven account.
Key points
- SC1: Misfolded tau and alpha-synuclein template conversion of homologous recipient protein. — HSEF Γ, Moderate confidence.
- SC2: Endogenous pathological species spread between cells in disease-relevant circuits. — HSEF Γ, Moderate confidence.
- SC3: Templated intercellular spread is a causal driver of progressive neuronal loss. — HSEF Γ, Moderate confidence.
- SC4: Prion-like mechanisms explain disease-class progression beyond forced inoculation. — HSEF Γ, Moderate confidence.
Verdict and review details
- Evidence grade
- HSEF Γ — Mechanistically plausible, partial system support
- Confidence
- Moderate
- Framework
- HSEF v5.3
- Review date
- Literature cutoff
- Published
- Review attribution (recorded)
- Codex
Evidence scope: 66 primary reports; literature cutoff 2026-10-06; source examination UTC date 2026-10-06; bounded critical review, not exhaustive systematic review.
The grade applies to the stated claim. Model rankings and individual subclaim grades remain separate from the overall causal-evidence grade.
Full scientific assessment and references · Scorecard (JSON) · Review source (Markdown)
The result at a glance
Damaged proteins can spread in experiments. That does not establish spread as the main driver of natural disease.
Read the labels in this illustration
THE MAIN FINDING Damaged proteins can spread in experiments. That does not establish spread as the main driver of natural disease. The idea Does the spread of damaged proteins from cell to cell drive brain degeneration? Damaged proteins spread Convert cell to cell Drive degeneration Proposed chain — plausible, not established What fits better Some nerve cells are more vulnerable Best fit in this review Same protein load — different injury spread happens injured resists varies Cell identity and internal handling decide the injury Spread arrows are dashed: observed in experiments What remains uncertain Why certain nerve cells resist damage longer How much spread contributes in natural disease What separates harmless transfer from harmful conversion Evidence comes from cells, animals, and people — each setting carries different weight. Cell identity and internal protein handling help explain injury beyond where protein material travels. Conceptual illustration
Best fit in this review
Some nerve cells are more vulnerable
Cell identity and internal protein handling help explain injury beyond where protein material travels.
Evidence for the stated claim
Plausible, not established
A higher rank means a better fit to the evidence in this comparison. It does not prove every part of the leading explanation.
Which explanation fits?
Another explanation fits better.
A separate question from the causal evidence grade
How does this explanation compare with alternatives?
Alternative ranked aheadThe reviewed hypothesis ranks 3 among 5 models compared; 1 alternative model(s) hold first rank for this stated claim.
Claim under review: rank 3 among 5 compared models.
Leading explanation: Selective vulnerability.
Position in this comparison: Between leading and last ranks.
The causal grade asks how well the stated causal claim is established. This comparison asks which of the assessed explanations fits the reviewed findings better. A leading explanation can remain unproven. Models can overlap or include the tested mechanism; an alternative ahead does not make that mechanism irrelevant. These ordinal ranks apply within this review; they do not measure the size of a difference or rank scientific strength across topics.
Read the labels in this illustration
TWO EXPLANATIONS, COMPARED A · The idea under review Does the spread of damaged proteins from cell to cell drive brain degeneration? Proposed chain Proteins spread Convert cell to cell Drive degeneration Each arrow is a proposal, not a proven step. Cell identity and internal protein handling help explain injury beyond where protein material travels. B · Leading explanation Some nerve cells are more vulnerable Another explanation fits better injured resists Vulnerability decides the injury A better fit is not proof of every part of the explanation. These explanations can overlap. Conceptual illustration
Idea being tested · rank 3
Does the spread of damaged proteins from cell to cell drive brain degeneration?
Plausible, not established for the stated claim.
Best fit in this review · rank 1
Some nerve cells are more vulnerable
Cell identity and internal protein handling help explain injury beyond where protein material travels.
These explanations can overlap. Ranking their fit to the evidence is separate from deciding how firmly a cause has been established.
See all the explanations compared
Rank 1: Selective vulnerability — Neuronal identity and intrinsic proteostasis condition aggregate susceptibility and injury.
Rank 2: Host-state determinism — Substrate amount, lysosomes and intracellular interactions determine pathogenic response.
Rank 3: Templated protein propagation — Transferred species recruit host protein and advance regional pathology.
Rank 4: Spread without toxicity — Cargo movement or seeded accumulation can occur without sustained neuronal injury.
Rank 5: Glial vector propagation — Microglial vesicles and processing contribute to model spread.
What this means
?
Plausible, not established
Damaged proteins can spread in experiments. That does not establish spread as the main driver of natural disease.
Evidence rating: Γ · Moderate confidence. How the evidence was assessed.
The important distinction
Cell identity and internal protein handling help explain injury beyond where protein material travels.
Health and treatment
This is an assessment of a causal explanation, not proof that a particular supplement, diet, test, or treatment improves health. A treatment claim needs studies that test the intervention in people and measure meaningful benefits and harms. These findings can help frame research and informed clinical questions, but they do not identify what is right for one person.
From an idea to an explanation
Seeing two things together does not prove one causes the other.
What is observed?
Look for the proposed factor and the outcome, in the people or systems covered by the claim.
What else explains it?
Some nerve cells are more vulnerable. Cell identity and internal protein handling help explain injury beyond where protein material travels.
What test tells them apart?
Block transfer without lowering the protein source, measuring conversion and nerve-cell loss separately.
Key questions
The key parts of the idea
These illustrations show the key questions tested in the review. They are conceptual drawings, not microscope images or experimental results.
What to test next
What evidence would make the answer clearer?
Read the labels in this illustration
WHAT WOULD MAKE THE ANSWER CLEARER A research question Block transfer without lowering the protein source, measuring conversion and nerve-cell loss separately. then then Change the proposed cause Proposed test Transfer blocked, protein source unchanged transfer blocked protein source unchanged No block — comparison group Measure the relevant outcome Proposed test Protein conversion is measured converted? Nerve-cell loss is counted separately Measured in every group. Check the result independently Proposed test First team measures Second team repeats An independent check of the result. Same measures, fresh eyes — no shared data until the end. This storyboard shows the logic of a test. It does not show a result. The question is what blocking transfer changes — conversion, nerve-cell loss, or neither. Conceptual illustration
A useful next question
Block transfer without lowering the protein source, measuring conversion and nerve-cell loss separately.
Change the proposed cause
Check that the intended change really happened.
Measure the relevant outcome
Allow for other factors and compare with suitable controls.
Check whether it holds up
Look for independent confirmation and the limits of the effect.
These are questions for research, not a claim that the proposed studies have already succeeded.
Read the scientific study designs
Proposed tests: 1 test design(s) are registered in the scorecard.
In plain terms, researchers would change the proposed cause, check that it changed as intended, then measure a meaningful outcome while controlling plausible alternatives. The result should be able to support or count against the claim—not only show that a pathway exists.
Experiment 1: Registered boundary experiment
Study design: In independently generated spontaneous tau and alpha-synuclein disease systems with physiological donor/recipient substrate, interrupt a selective transfer or recipient-conversion step after onset and restore it with matched rescue.
What would be measured: Direct donor–recipient lineage, recipient conversion, regional pathology, blinded neuron survival and functional trajectory
Important controls: Source protein load, host physiology, intracellular toxicity, clearance and peripheral/glial responses
Result that would support the claim: Verified selective suppression slows recipient conversion and subsequent neuron loss; matched rescue reinstates both in each prespecified system
Result that would count against it: Verified selective suppression leaves progression unchanged or increases intracellular injury despite less transfer
Explore the evidence
Read the complete scientific review.
Follow the studies, detailed comparisons and evidence ratings behind this guide.
Open the scientific review →